Norco brand pain medication

Norco is a well-known prescription painkiller composed of a combination of acetaminophen and hydrocodone bitartrate. It is widely prescribed for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. Historically, the brand name Norco was established as a preferred alternative to earlier formulations like Vicodin because it minimized the ratio of acetaminophen to hydrocodone, reducing the risk of liver toxicity.

The pharmaceutical landscape for Norco has evolved significantly. Originally developed and marketed by Watson Pharmaceuticals, the brand became part of Allergan's portfolio following a series of major industry mergers and acquisitions. In 2020, AbbVie completed its acquisition of Allergan, bringing the Norco brand under its global umbrella. While the brand-name version of Norco has been discontinued in some markets in favor of generic equivalents, the formulation remains a standard in pain management therapy. Manufacturing typically occurs in high-standard pharmaceutical facilities across the United States and within the global supply chains of its parent corporation.